About Us
Premium Insights
Expert Views
Compliance
Experts
Careers
Contact Us
Senior General Manager, Research and Development (Sept 2017 - Feb 2023)
Tier 1Intas Pharmaceuticals, India
This author has not provided additional details yet.
Contact: +91 NA
Democrats push affordable meds for seniors, but biosimilars face hurdles. While generics cut $338B in costs, new rules may slow …
August 10, 2022
Biosimilar manufacturers frequently modify production processes. A comparability exercise ensures product quality, safety, and efficacy remain consistent pre- and post-change. …
July 5, 2021